Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 3—June 1999
Synopsis

Respiratory Diseases among U.S. Military Personnel: Countering Emerging Threats

Gregory C. Gray*Comments to Author , Johnny D. Callahan*†, Anthony W. Hawksworth*, Carol A. Fisher‡, and Joel C. Gaydos‡
Author affiliations: *Naval Health Research Center, San Diego, California, USA; †Naval Medical Center, San Diego, California, USA; and; ‡Walter Reed Army Institute of Research, Washington, DC, USA

Main Article

Figure 1

Hospitalization rates for acute respiratory disease per 10,000 persons, 1991 to 1994: U.S. army recruits vs. young adults in U.S. nonfederal hospitals. U.S. army recruit estimates are converted from percentage febrile acute respiratory disease rates per 100 trainee-week figures (8). On average, recruits were 19 years old. U.S. national nonfederal estimates were taken from first-listed diagnoses with the International Classification of Diseases codes 460 to 466 (9) among persons of ages 15 to 44

Figure 1. Hospitalization rates for acute respiratory disease per 10,000 persons, 1991 to 1994: U.S. army recruits vs. young adults in U.S. nonfederal hospitals. U.S. army recruit estimates are converted from percentage febrile acute respiratory disease rates per 100 trainee-week figures (8). On average, recruits were 19 years old. U.S. national nonfederal estimates were taken from first-listed diagnoses with the International Classification of Diseases codes 460 to 466 (9) among persons of ages 15 to 44 years (10-13).

Main Article

References
  1. Garibaldi  RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med. 1985;78:32–7. DOIPubMedGoogle Scholar
  2. Gray  G. Acute respiratory disease in the military. Federal Practioner. 1995;12:27–33.
  3. Pazzaglia  G, Pasternack  M. Recent trends of pneumonia morbidity in U.S. Naval personnel. Mil Med. 1983;148:647–51.PubMedGoogle Scholar
  4. Gray  G, Mitchell  B, Tueller  J, Cross  E, Amundson  D. Adult pneumonia hospitalizations in the U.S. Navy: rates and risk factors for 6,522 admissions, 1981-1991. Am J Epidemiol. 1994;139:793–802.PubMedGoogle Scholar
  5. Thomas  RJ, Conwill  DE, Morton  DE, Brooks  TJ, Holmes  CK, Mahaffey  WB. Penicillin prophylaxis for streptococcal infections in the United States Navy and Marine Corps recruit camps, 1951-1985. Rev Infect Dis. 1988;10:125–30.PubMedGoogle Scholar
  6. Gaydos  CA, Gaydos  JC. Adenovirus vaccines in the U.S. military. Mil Med. 1995;160:300–4.PubMedGoogle Scholar
  7. Dudding  BA, Top  FH, Winter  PE, Buescher  EL, Lamson  TH, Leibovitz  A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol. 1973;97:187–98.PubMedGoogle Scholar
  8. Brundage  JF, Gunzenhauser  JD, Longfield  JN, Rubertone  M, Ludwig  S, Rubin  F, Epidemiology and control of acute respiratory diseases with emphasis on group A beta-hemolytic streptococcus: a decade of U.S. Army experience. Pediatrics. 1996;97:964–70.PubMedGoogle Scholar
  9. U.S. Department of Health and Human Services. The international classification of diseases. 9th revision. Clinical modification. Washington: U.S. Department of Health and Human Services; 1989.
  10. Graves  EJ. National hospital discharge survey: annual summary, 1991. Vital Health Stat 13. 1993;:1–62.PubMedGoogle Scholar
  11. Graves  EJ. National hospital discharge survey: annual summary, 1992. Vital Health Stat 13. 1994;:1–63.
  12. Graves  EJ. National hospital discharge Survey: annual summary, 1993. Vital Health Stat 13. 1995;:1–63.
  13. Graves  EJ, Gillum  BS. National hospital discharge survey: annual summary, 1994. Vital Health Stat 13. 1997;i-v:1–50.
  14. Enders  J, Bell  J, Dingle  J, Francis  T Jr, Hilleman  M, Huebner  R, Adenoviruses: group name proposed for new respiratory tract viruses. Science. 1956;124:119–20. DOIPubMedGoogle Scholar
  15. Hilleman  M. Efficacy of and indications for use of adenovirus vaccine. Am J Public Health. 1958;48:153–8. DOIGoogle Scholar
  16. Miller  LF, Tytel  M, Pierce  WE, Rosenbaum  MJ. Epidemiology of nonbacterial pneumonia among naval recruits. JAMA. 1963;185:92–9.
  17. Hilleman  M, Gauld  R, Butler  R, Stallones  R, Hedberg  C, Warfield  M, Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg. 1957;66:29–41.PubMedGoogle Scholar
  18. Grayston  J. Studies in civilian populations. American Reviews of Respiratory Disease 1963;88 supl:94-109.
  19. McNamara  MJ, Pierce  WE, Crawford  YE, Miller  LF. Patterns of adenovirus infection in the respiratory diseases of naval recruits. Am Rev Respir Dis. 1962;86:485–97.PubMedGoogle Scholar
  20. Top  FH Jr. Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J Biol Med. 1975;48:185–95.PubMedGoogle Scholar
  21. Goswami  P, Hawksworth  A, McDonough  C, Morn  C, Mullen  M, Ryan  M, An epidemic of adenovirus infections among military recruits. Atlanta (GA): American Society for Microbiology; 1998.
  22. McNeill  K, Hendrix  R, Benton  F, Gray  G, Gaydos  J. The first reported outbreak of respiratory disease due to adenovirus type 4 in otherwise healthy young women. Proceedings of the International Conference on Emerging Infectious Diseases; 1998 Mar 8-11; Atlanta, Georgia.
  23. Grayston  JT, Woolridge  RI, Loosli  CG, Gundelfinder  BF, Johnson  PB, Pierce  WE. Adenovirus infections in naval recruits. J Infect Dis. 1959;104:61–70.PubMedGoogle Scholar
  24. Foy  HM. Adenoviruses. In: Evans AS, editor. Viral infections of humans. New York: Plenum Medical Book Company; 1989. p. 77-94.
  25. Gray  G, Goswami  P, Hawksworth  A, Callahan  J, Greenup  R, Hendrix  R, National adenovirus surveillance and typing among high risk military populations. Proceedings of the International Conference on Emerging Infectious Diseases; 1998 Mar 8-11; Atlanta, Georgia.
  26. Surgeon General  USN. Annual report of the Surgeon General, U.S. Navy to the Secretary of the Navy for the fiscal year 1919. Washington: Government Printing Office; 1919.
  27. Update: isolation of avian influenza A(H5N1) viruses from humans—Hong Kong, 1997-1998. MMWR Morb Mortal Wkly Rep. 1998;46:1245–7.PubMedGoogle Scholar
  28. Williams  R, Cox  N, Regnery  H, Noah  D, Khan  A, Miller  J, Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med. 1997;162:82–6.PubMedGoogle Scholar
  29. Gambel  J, Shlim  D, Canas  L, Cox  N, Regnery  H, Scott  R, Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillance. Emerg Infect Dis. 1998;4:128–30. DOIPubMedGoogle Scholar
  30. Hirsch  EF, McKinney  M. An epidemic of pneumococcus bronchopneumonia. J Infect Dis. 1919;24:594–617.
  31. Reichler  M, Reynolds  R, Schwartz  B, Musher  D, Pratt  G, Hohenhaus  J, Epidemic of pneumococcal pneumonia at a military training camp. In: Proceedings of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology; 1991 September 29 - October 2; Chicago, Illinois.
  32. Musher  D, Groover  J, Reichler  M, Riedo  F, Schwartz  B, Watson  D, Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997;24:441–6.PubMedGoogle Scholar
  33. Gray  G, McPhate  D, Leinonen  M, Cassell  G, Deperalta  E, Putnam  S, Weekly oral azithromycin as prophylactic therapy against bacterial causes of acute respiratory disease. Clin Infect Dis. 1998;26:103–10. DOIPubMedGoogle Scholar
  34. Lee  HJ, Park  JY, Jang  SH, Kim  JH, Kim  EC, Choi  KW. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis. 1995;20:826–35.PubMedGoogle Scholar
  35. Barile  A, Driscoll  T, Harley  D, Haberberger  R, Wallace  M. Increasing incidence of penicillin-resistant Streptococcus pneumoniae. Proceedings of the IDSA 35th Annual Meeting [abstract]; 1997 September 13-16; San Francisco, California.
  36. Fairchok  MP, Ashton  WS, Fisher  GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates. Clin Infect Dis. 1996;22:966–72.PubMedGoogle Scholar
  37. Hawksworth  A, Goswami  P, Kelley  P, Gray  G. National Department of Defense surveillance for emerging respiratory pathogens. Proceeding of the International Conference on Emerging Infectious Diseases; 1998 Mar 8-11; Atlanta, Georgia.
  38. Pepper  P. Cost effectiveness of the pneumococcal vaccine in the Navy and Marine Corps. Stanford: Stanford University; 1998.
  39. Gray  GC, Escamilla  J, Hyams  KC, Struewing  JP, Kaplan  EL, Tupponce  AK. Hyperendemic Streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine. N Engl J Med. 1991;325:92–7.PubMedGoogle Scholar
  40. Gunzenhauser  JD, Brundage  JF, McNeil  JG, Miller  RN. Broad and persistent effects of benzathine penicillin G in the prevention of febrile, acute respiratory disease. J Infect Dis. 1992;166:365–73.PubMedGoogle Scholar
  41. Naval Medical Research Unit No. 4. History and accomplishments. An introduction to NAMRU-4. Great Lakes (IL): Naval Medical Research Unit No. 4; 1972.
  42. Massell  BF, Dow  JW, Jones  TD. Orally administered penicillin in patients with rheumatic fever. JAMA. 1948;138:1030.
  43. Davis  J, Schmidt  WC. Benzathine penicillin G effectiveness in the prevention of streptococcal infections in a heavily exposed population. N Engl J Med. 1957;256:339–42.PubMedGoogle Scholar
  44. Denny  F. A 45-year perspective on the Streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clin Infect Dis. 1994;19:1110–22.PubMedGoogle Scholar
  45. Fujikawa  J, Struewing  JP, Hyams  KC, Kaplan  EL, Tupponce  AK, Gray  GC. Oral erythromycin prophylaxis against Streptococcus pyogenes infections in penicillin-allergic military recruits: a randomized clinical trial. J Infect Dis. 1992;166:162–5.PubMedGoogle Scholar
  46. Veasy  L, Wiedmeier  S, Orsmond  G, Ruttenberg  H, Boucek  M, Roth  S, Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 1987;316:421–7.PubMedGoogle Scholar
  47. Wallace  MR, Garst  PD, Papadimos  TJ, Oldfield  EC. The return of acute rheumatic fever in young adults. JAMA. 1989;262:2557–61. DOIPubMedGoogle Scholar
  48. Acute rheumatic fever among Army trainees—Fort Leonard Wood, Missouri. MMWR Morb Mortal Wkly Rep. 1988;37:519–22.PubMedGoogle Scholar
  49. Riseman  JA, Zamboni  WA, Curtis  A, Graham  DR, Konrad  HR, Ross  DS. Hyperbaric oxygen therapy for necrotizing fasciitis mortality and the need for debridements. Surgery. 1990;108:847–50.PubMedGoogle Scholar
  50. American Academy of Pediatrics. Committee on Infectious Diseases. Severe Invasive Group A Streptococcal Infections: A Subject. Rev Pediatr. 1998;101:136–40.
  51. Stevens  D, Tanner  M, Winship  J, Swarts  R, Ries  K, Schlievert  P, Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1–7.PubMedGoogle Scholar
  52. Hoge  CW, Schwartz  B, Talkington  DF, Breiman  RF, MacNeil  EM, Englender  SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA. 1993;269:384–9. DOIPubMedGoogle Scholar
  53. Schwartz  B, Facklam  R, Breiman  R. Changing epidemiology of group A streptococcal infection in the USA. Lancet. 1990;:1167–71. DOIPubMedGoogle Scholar
  54. Gunzenhauser  JD, Longfield  JN, Brundage  JF, Kaplan  EL, Miller  RN, Brandt  CA. Epidemic streptococcal disease among Army trainees, July 1989 through June 1991. J Infect Dis. 1995;172:124–31.PubMedGoogle Scholar
  55. Coonan  KM, Kaplan  EL. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J. 1994;13:630–5. DOIPubMedGoogle Scholar
  56. Chanock  RM, Mufson  MA, Bloom  HH, James  WD, Fox  HH, Kingston  JR. Eaton agent pneumonia. JAMA. 1961;175:213–4.PubMedGoogle Scholar
  57. Commission on Acute Respiratory Diseases. Epidemiology of atypical pneumonia and acute respiratory disease at Fort Bragg, North Carolina. Am J Public Health. 1944;34:335–46. DOIGoogle Scholar
  58. Eaton  MD, Meiklejohn  G, Van Herick  W. Studies on the etiology of primary atypical pneumonia: a filterable agent transmissible to cotton rats, hamsters, and chick embryos. J Exp Med. 1944;79:649–68. DOIPubMedGoogle Scholar
  59. Chanock  RM, Rifkind  MD, Kravetz  HM, Knight  V, Johnson  KM. Respiratory disease in volunteers infected with Eaton agent: a preliminary report. Proc Natl Acad Sci U S A. 1961;47:887–90. DOIPubMedGoogle Scholar
  60. Cassell  G. Severe mycoplasma disease—rare or underdiagnosed? West J Med. 1995;:172–5.PubMedGoogle Scholar
  61. Edwards  EA, Crawford  YE, Pierce  WE, Peckinpaugh  RO. A longitudinal study of Mycoplasma pneumoniae infections in Navy recruits by isolation and seroepidemiology. Am J Epidemiol. 1976;104:556–62.PubMedGoogle Scholar
  62. Gray  GC, Duffy  LB, Paver  RJ, Putnam  SD, Reynolds  RJ, Cassell  GH. Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S. Marines in southern California. Mil Med. 1997;162:524–6.PubMedGoogle Scholar
  63. Gray  GC, Hyams  KC, Wang  SP, Grayston  JT. Mycoplasma pneumoniae and Chlamydia pneumoniae strain TWAR infections in U.S. Marine Corps recruits. Mil Med. 1994;159:292–4.PubMedGoogle Scholar
  64. Mogabgab  WJ. Protective effects of inactive Mycoplasma pneumoniae vaccine in military personnel 1964-1966. Am Rev Respir Dis. 1968;97:359–65.PubMedGoogle Scholar
  65. McCormick  DP, Wenzel  RP, Senterfit  LB, Bean  WE. Relationship of pre-existing antibody to subsequent infection by Mycoplasma pneumoniae in adults. Infect Immun. 1974;9:53–9.PubMedGoogle Scholar
  66. Steinberg  P, White  R, Fuld  S, Gutekunst  R, Chanock  R, Senterfit  L. Ecology of Mycoplasma pneumoniae infections in Marine recruits at Parris Island, South Carolina. Am J Epidemiol. 1969;:62–73.PubMedGoogle Scholar
  67. Wenzel  RP, Craven  RB, Davies  JA, Hendley  JO, Hamory  BH, Gwaltney  JM. Field trial of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis. 1976;134:571–6.PubMedGoogle Scholar
  68. Smith  C, Friedewald  W, Chanock  R. Inactivated Mycoplasma pneumoniae vaccine. JAMA. 1967;:353–8. DOIPubMedGoogle Scholar
  69. Jensen  KJ, Senterfit  LB, Scully  WE, Conway  TJ, West  RF, Drummy  WW. Mycoplasma pneumoniae infections in children, and epidemiologic appraisal in families with oxytetracycline. Am J Epidemiol. 1967;86:419–32.PubMedGoogle Scholar
  70. Bass  JW, Stephenson  SR. The return of pertussis. Pediatr Infect Dis J. 1987;6:141–4. DOIPubMedGoogle Scholar
  71. Pertussis outbreaks—Massachusetts and Maryland, 1992. MMWR Morb Mortal Wkly Rep. 1993;42:197–200.PubMedGoogle Scholar
  72. Pertussis outbreak—Vermont, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:822–6.PubMedGoogle Scholar
  73. Jansen  DL, Gray  GC, Putnam  SD, Lynn  F, Meade  BD. Evaluation of pertussis infection among US Marine Corps trainees. Clin Infect Dis. 1997;25:1099–107. DOIPubMedGoogle Scholar
  74. Mink  CM, Cherry  JD, Christenson  P, Lewis  K, Pineda  E, Shlian  D, A search for Bordetella pertussis infection in university students. Clin Infect Dis. 1992;14:464–71.PubMedGoogle Scholar
  75. Jenkinson  D. Natural course of 500 consecutive cases of whooping cough: a general practice population study. Lancet. 1995;310:299–302.
  76. Cherry  J. Nosocomial pertussis in the nineties. Infect Control Hosp Epidemiol. 1995;16:553–5. DOIPubMedGoogle Scholar
  77. Skekett  R, Wassilak  S, Adkins  W, Burstyn  D, Manclark  C, Berg  J, Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis. 1988;157:434–40.PubMedGoogle Scholar
  78. Weber  D, Rutala  W. Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol. 1994;15:411–5. DOIPubMedGoogle Scholar
  79. Dodhia  H, Miller  E. Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. Epidemiol Infect. 1998;120:143–9. DOIPubMedGoogle Scholar
  80. Advisory Committee on Immunization Practices. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR Morb Mortal Wkly Rep. 1996;46:1–25.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external